References
- Eisenberg D M, Davis R B, Ettner S L, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280(18)1569–1575
- Astin J A. Why patients use alternative medicine. JAMA 1998; 279: 1548–1553
- Kaptchuk T J, Eisenberg D M. The persuasive appeal of alternative medicine. Ann Intern Med 1998; 129(12)1061–1065
- Ernst D. Harmless Herbs? A review of the recent literature. Am J Med 1998; 104: 170–178
- Greenblatt R M, Hollander H, McMaster J R, Henke C J. Polypharmacy among patients attending an AIDS clinic: Utilization of prescribed, unorthodox, and investi-gational treatments. J Acquired Immune Defic Syndr 1991; 151: 2281–2282
- Kassler W J, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991; 79: 1098–1101
- Cassileth B R, Lusk E J, Guerry D P, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. NEJM 1991; 324: 1180–1185
- Rowland L P, Shneider N A. Amyotrophic Lateral Sclerosis. NEJM 2001; 344(22)1688–1700
- Wasner M, Klier H, Borasio G D. The use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci 2001; 191: 151–154
- Coleman L M, Fowler L L, Williams M E. Use of unproven therapies by people with alzheimer’s disease. J Am Geriatr Soc 1995; 43: 747–750
- Schwartz C E, Laitin E, Brotman S. Utilization of unconventional treatments by persons with MS: Is it alternative or complementary?. Neurology 1999; 52: 626–629
- Rajendran P R, Thompson R E, Reich S G. The use of alternative therapies by patients with Parkinson’s disease. Neurology 2001; 57: 790–794
- Miller R G, Moore D, Young L A, et al. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyo-trophic Lateral Sclerosis Study Group. Neurology 1996; 47(6)1383–8
- Miller R G, Moore D H, 2nd, Gelinas D F, et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56(7)843–8